Daddy's SUPG. Dacogen approval open so many new doors. Making long term growth a reality. The longs saw this opportunity and held through the bad and now the good. Our research saw the opportunity and we spent considerable time outlining this small biotech's accomplishments and future revenue opportunities. This is just the beginning and we should see several nice announcements in the coming weeks. This company's strong balance sheet, no debt, continue pipeline, growing revenue picture, experience on bring a drug to market. This should be a nice ride.